Rathbones Group PLC Eli Lilly & CO Transaction History

Rathbones Group PLC

$19 Billion
Q3 2024

A detailed history of Rathbones Group PLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Rathbones Group PLC holds 156,896 shares of LLY stock, worth $121 Million. This represents 0.73% of its overall portfolio holdings.

Number of Shares

156,896

Previous 129,360 21.29%

Holding current value

$121 Million

Previous $117 Million 18.68%

% of portfolio

0.73%

Previous 0.66%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$772.14 - $960.02 $21.3 Million - $26.4 Million	27,536 Added 21.29%	156,896 $139 Million
Q2 2024 Aug 09, 2024	BUY	$724.87 - $909.04 $23.3 Million - $29.2 Million	32,152 Added 33.08%	129,360 $117 Million
Q1 2024 May 14, 2024	BUY	$592.2 - $792.28 $13.6 Million - $18.1 Million	22,886 Added 30.79%	97,208 $75.6 Million
Q4 2023 Feb 13, 2024	BUY	$525.19 - $619.13 $1.1 Million - $1.3 Million	2,100 Added 2.91%	74,322 $43.3 Million
Q3 2023 Nov 13, 2023	BUY	$434.7 - $599.3 $6.87 Million - $9.47 Million	15,803 Added 28.01%	72,222 $38.8 Million
Q2 2023 Aug 04, 2023	SELL	$350.74 - $468.98 $720,770 - $963,753	-2,055 Reduced 3.51%	56,419 $26.5 Million
Q1 2023 May 12, 2023	SELL	$310.63 - $364.82 $245,087 - $287,842	-789 Reduced 1.33%	58,474 $20.1 Million
Q4 2022 Feb 14, 2023	SELL	$321.55 - $374.67 $1.45 Million - $1.69 Million	-4,501 Reduced 7.06%	59,263 $21.7 Million
Q3 2022 Nov 03, 2022	SELL	$296.48 - $337.87 $2.9 Million - $3.31 Million	-9,789 Reduced 13.31%	63,764 $20.6 Million
Q2 2022 Aug 12, 2022	SELL	$278.73 - $327.27 $564,706 - $663,049	-2,026 Reduced 2.68%	73,553 $23.8 Million
Q1 2022 May 11, 2022	SELL	$234.69 - $291.66 $327,861 - $407,449	-1,397 Reduced 1.81%	75,579 $21.6 Million
Q4 2021 Feb 10, 2022	SELL	$224.85 - $279.04 $658,135 - $816,750	-2,927 Reduced 3.66%	76,976 $21.3 Million
Q3 2021 Nov 04, 2021	SELL	$221.6 - $272.71 $561,756 - $691,319	-2,535 Reduced 3.08%	79,903 $18.5 Million
Q2 2021 Jul 30, 2021	BUY	$180.55 - $233.54 $310,907 - $402,155	1,722 Added 2.13%	82,438 $18.9 Million
Q1 2021 May 14, 2021	SELL	$164.32 - $212.72 $133,263 - $172,515	-811 Reduced 0.99%	80,716 $15.1 Million
Q4 2020 Feb 11, 2021	SELL	$130.46 - $172.63 $214,345 - $283,631	-1,643 Reduced 1.98%	81,527 $13.8 Million
Q3 2020 Nov 13, 2020	BUY	$146.22 - $169.13 $159,087 - $184,013	1,088 Added 1.33%	83,170 $12.3 Million
Q2 2020 Aug 07, 2020	SELL	$136.42 - $164.18 $255,378 - $307,344	-1,872 Reduced 2.23%	82,082 $13.5 Million
Q1 2020 May 04, 2020	SELL	$119.05 - $147.35 $420,246 - $520,145	-3,530 Reduced 4.04%	83,954 $11.6 Million
Q4 2019 Feb 11, 2020	BUY	$106.92 - $132.43 $466,171 - $577,394	4,360 Added 5.25%	87,484 $11.5 Million
Q3 2019 Nov 13, 2019	BUY	$106.79 - $116.16 $300,079 - $326,409	2,810 Added 3.5%	83,124 $9.3 Million
Q2 2019 Aug 12, 2019	SELL	$110.79 - $129.32 $125,857 - $146,907	-1,136 Reduced 1.39%	80,314 $8.9 Million
Q1 2019 May 09, 2019	SELL	$111.31 - $131.02 $85,152 - $100,230	-765 Reduced 0.93%	81,450 $10.6 Million
Q4 2018 Feb 12, 2019	BUY	$105.9 - $118.64 $736,640 - $825,259	6,956 Added 9.24%	82,215 $9.51 Million
Q3 2018 Oct 12, 2018	SELL	$85.86 - $107.31 $28,763 - $35,948	-335 Reduced 0.44%	75,259 $8.08 Million
Q2 2018 Jul 16, 2018	SELL	$75.7 - $86.88 $426,948 - $490,003	-5,640 Reduced 6.94%	75,594 $6.45 Million
Q1 2018 Apr 06, 2018	SELL	$74.21 - $87.6 $165,859 - $195,786	-2,235 Reduced 2.68%	81,234 $6.29 Million
Q4 2017 Jan 24, 2018	SELL	$81.94 - $87.89 $360,617 - $386,803	-4,401 Reduced 5.01%	83,469 $7.05 Million
Q3 2017 Oct 24, 2017	BUY	$77.07 - $85.54 $6.77 Million - $7.52 Million	87,870	87,870 $7.52 Million

Others Institutions Holding LLY

# of Institutions

4,012

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $735B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rathbones Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Rathbones Group PLC with notifications on news.

Account

Rathbones Group PLC Eli Lilly & CO Transaction History